| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/20/1991 | EP0406307A4 Water soluble ibuprofen compositions and methods of making them |
| 03/19/1991 | US5001236 Benzothiazepines |
| 03/19/1991 | US5001159 N-aminobutyl-n-phenylarylamide compounds and their application in therapy |
| 03/19/1991 | US5001142 Alzheimer's disease |
| 03/19/1991 | US5001135 Indole derivatives |
| 03/19/1991 | US5001130 Psychotropic heterobicycloalkylpiperazine derivatives |
| 03/19/1991 | US5001124 4-isoxazolecarboxamide derivatives |
| 03/19/1991 | US5001117 Use of lecithin to restore olfaction and taste |
| 03/19/1991 | CA2025524A1 Pharmacologically active compound, preparation and use |
| 03/19/1991 | CA1281850C Process for producing novel crystals of n _ -¬¬(s)-4-oxo-2-azetidinyl|-carbonyl|-l-histidyl-l- prolinamide |
| 03/17/1991 | WO1991004252A1 New esters of thienyl carboxylic acids and amino alcohols, their quaternization products, and manufacture and use of said compounds |
| 03/17/1991 | CA2025358A1 Treatment |
| 03/16/1991 | WO1991004316A2 Ciliary neurotrophic factor |
| 03/16/1991 | CA2040404A1 Ciliary neurotrophic factor |
| 03/13/1991 | EP0417027A1 Tetracyclic imidazoquinazoline derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/13/1991 | EP0416754A2 A novel substituted pyrazine, formulations thereof and use in medicine |
| 03/13/1991 | EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
| 03/13/1991 | CA2024723A1 Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same |
| 03/12/1991 | US4999430 Analgesics, treatment of Alzheimer*s disease, cognition activators |
| 03/12/1991 | US4999382 Compositions for treating tobacco withdrawal symptoms and methods for their use |
| 03/12/1991 | US4999372 New aminochromanol compounds |
| 03/12/1991 | US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system |
| 03/12/1991 | US4999367 Ethers of 1-benzyl-3-hydroxymethyl-indazole with aliphatic 2-hydroxyacids, compositions and use |
| 03/12/1991 | US4999359 Heterocyclic ethylene diamine compounds and their pharmaceutical compositions and methods |
| 03/12/1991 | US4999358 Treatment of Memory Dysfunctions, Alzheimer's Disease |
| 03/12/1991 | US4999354 Imidazoquinoxaline compounds and their preparation and use |
| 03/12/1991 | US4999353 Anticonvulsant and Anxiolytic Agents |
| 03/12/1991 | US4999352 Antidepressants or fungicides |
| 03/12/1991 | US4999349 BU-4164E - A and B, prolyl endopeptidase inhibitors |
| 03/12/1991 | US4999226 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination |
| 03/12/1991 | CA2025003A1 Use of dopamine-autoreceptor agonists in the treatment of drug dependency |
| 03/12/1991 | CA2024996A1 3-(1-substituted-4-piperazinyl}-1h-indazoles, a process for their preparation and their use as medicaments |
| 03/12/1991 | CA2024661A1 Peptidase and isomerase inhibitors |
| 03/12/1991 | CA1281334C Indole derivatives |
| 03/12/1991 | CA1281325C Benzofuran derivatives |
| 03/09/1991 | WO1991003478A1 Tetracyclic imidazoquinazoline derivatives, preparation and pharmaceutical compositions |
| 03/09/1991 | WO1991003475A1 Substituted urea compounds and their preparation and use |
| 03/09/1991 | WO1991003243A1 Antipsychotic 1-cycloalkylpiperidines |
| 03/09/1991 | CA2066696A1 Substituted urea compounds and their preparation and use |
| 03/09/1991 | CA2066695A1 Tetracyclic imidazoquinazoline derivatives, preparation and pharmaceutical compositions |
| 03/09/1991 | CA2064219A1 Antipsychotic 1-cycloalkylpiperidines |
| 03/07/1991 | WO1991002788A1 Herpes simplex virus type 1 mutant |
| 03/07/1991 | WO1991002721A1 5-(1-aminocyclohexyl)-2(1h)-pyridinone and related compounds |
| 03/07/1991 | WO1991002718A1 Novel amino acid derivatives, method for preparing them, and their therapeutical applications |
| 03/07/1991 | CA2064592A1 Amino acid derivatives, their preparation process and their therapeutic applications |
| 03/06/1991 | EP0415693A1 Composition and method for selective enhancement of opiate activity and reduction of opiate tolerance and dependence |
| 03/06/1991 | EP0415634A2 Benzazabicyclic carbamates as cholinesterase inhibitors |
| 03/06/1991 | EP0415612A2 Use of sertraline for the treatment of chemical dependencies |
| 03/06/1991 | EP0415321A1 Oligodendrocyte cytotoxic factor |
| 03/06/1991 | EP0415103A1 2,3-Dihydro-1-(pyridinylamino)-indoles, a process for their preparation and their use as medicaments |
| 03/06/1991 | EP0415102A1 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments |
| 03/06/1991 | EP0415065A1 Chroman derivatives |
| 03/06/1991 | EP0415030A2 1-Substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[1,5-A]pyrimidine-8-carbonitriles |
| 03/06/1991 | EP0414903A1 New thioproline derivative |
| 03/06/1991 | EP0414895A1 OROTATE OF $g(a)-AMINO-$g(b)-PHENYL-BUTYRIC ACID |
| 03/06/1991 | CN1049660A Aminoketone derivatives and use thereof |
| 03/05/1991 | US4997846 Smooth muscle relaxants, hypotensives |
| 03/05/1991 | US4997841 Indole derivatives |
| 03/05/1991 | US4997839 2-quinolyl ethers |
| 03/05/1991 | US4997831 Lactam derivatives |
| 03/05/1991 | CA1281029C Optically active ketals, processes for their preparation and their use in the synthesis of ó-arylakanoic acids |
| 03/02/1991 | CA2021548A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/01/1991 | CA2024030A1 Oligodendrocyte cytotoxic factor |
| 03/01/1991 | CA2024011A1 1-substituted-1,2-dihydro-4-[(substituted)-phenyl]imidazo-[ 1,5-a]pyrimidine-8-carbonitriles |
| 02/27/1991 | EP0414422A2 2-Oxo-1-oxa-8-azaspiro [4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/27/1991 | EP0414421A2 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof |
| 02/27/1991 | EP0414394A2 Azabicyclic Derivatives having muscarinic receptor affinity |
| 02/27/1991 | EP0414391A2 Aminoketone derivatives and use thereof |
| 02/27/1991 | EP0414289A1 Spirocyclic antipsychotic agents |
| 02/27/1991 | EP0414263A2 Process for the stabilisation of a solid pharmaceutical composition comprising cyclic amino acids. |
| 02/27/1991 | EP0414020A2 Process for the preparation of clausenamide and neoclausenamide and their derivatives |
| 02/27/1991 | EP0414018A2 Process for the preparation of dehydrocycloclausenamide and its derivatives in the racemic form and as optically active (+)- or (-)-enantiomers |
| 02/27/1991 | EP0413929A2 Use of an ace-inhibitor to treat or prevent depression |
| 02/27/1991 | EP0413751A1 Neurologically active compounds |
| 02/26/1991 | WO1991002725A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs |
| 02/26/1991 | WO1991002522A1 Onset-hastened/enhanced antipyretic response |
| 02/26/1991 | US4996318 Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke |
| 02/26/1991 | US4996235 3,4-diphenylbutanamines |
| 02/26/1991 | US4996224 1-benzyl-4- or 5-pyrrolidinomethyl-pyrrolidin-2-ones and nootropic method of use thereof |
| 02/26/1991 | US4996218 Chloroaniline derivatives |
| 02/26/1991 | US4996213 Derivatives of 4-amino 3-carboxy naphthyridines and their pharmaceutical compositions |
| 02/26/1991 | US4996211 Anticonvulsants, treating neurodegenerative diseases |
| 02/26/1991 | US4996210 Cognition activators, nervous system disorders; muscarinic acetylcholine receptor agonists; 2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4.5]decane for example |
| 02/26/1991 | US4996204 Antidiabetic agents |
| 02/26/1991 | US4996201 Alzheimer's disease |
| 02/26/1991 | CA2064999A1 1,2,3,4-tetrahydroacridin-5-amine derivatives and their use as therapeutic agents |
| 02/26/1991 | CA2023957A1 Cyclic ketone derivatives and pharmaceutical compositions containing same as well as a process for their preparation |
| 02/26/1991 | CA1280751C 6.alpha.-AMINO-3-AZABICYCLO ¬3.3.1| NONANE DERIVATIVES |
| 02/21/1991 | WO1991002067A1 Regulation of nerve growth factor synthesis in the central nervous system |
| 02/21/1991 | WO1991001994A1 11β-SUBSTITUTED 16α,17α-METHYLENE-ESTRA-4,9-DIENE-3-ONES |
| 02/21/1991 | WO1991001993A1 ANTIGESTAGENIC 11β-ARYL-16α,17α-CYCLOHEXANO-ESTRA-4,9-DIENES |
| 02/21/1991 | WO1991001958A2 11β-ARYL-GONA-4,9-DIEN-3-ONES |
| 02/21/1991 | WO1991000725A3 Amino acid analog cck antagonists |
| 02/20/1991 | EP0413667A1 Halogenoalkyl-phenyl-alcohols, -ketones and their hydrates |
| 02/20/1991 | EP0413545A2 Azabicyclic compounds |
| 02/20/1991 | EP0413516A2 4-Methylene-1-oxa-2-oxo-8-azaspiro[4,5]decane derivatives, pharmaceutical compositions containing them and processes for preparing them |
| 02/20/1991 | EP0413433A1 Isoindolyl-imidazole-derivatives and pharmaceutical compositions |
| 02/20/1991 | EP0413300A1 Pyrido [3,4-b][1,4] benzoxazepines, a process for their preparation and their use as medicaments |
| 02/20/1991 | EP0413191A1 1-(Pyridinylamino)-2-pyrrolidinones, a process for their preparation and their use as medicaments |
| 02/20/1991 | EP0413171A1 Strong analgesic composition and process for its preparation |